Provided by Tiger Fintech (Singapore) Pte. Ltd.

Equillium Inc.

0.4201
-0.0200-4.54%
Pre-market: 0.45600.0359+8.55%08:00 EDT
Volume:72.24K
Turnover:31.03K
Market Cap:15.01M
PE:-1.84
High:0.4447
Open:0.4405
Low:0.4101
Close:0.4401
Loading ...

Press Release: West Completes Sale of Notified to Equiniti

Dow Jones
·
36 mins ago

Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504

Business Wire
·
1 hour ago

EQ Inc. Achieves Profitability and Growth in 2024

TIPRANKS
·
12 hours ago

FirstEnergy Recognized by Ethisphere® for Outstanding Ethics and Compliance Program and Practices and Leadership

PR Newswire
·
17 hours ago

Leerink says Equillium’s itolizumab news ‘disappointing but not surprising’

TIPRANKS
·
25 Apr

Equillium says FDA declines Breakthrough Therapy designation for itolizumab

TIPRANKS
·
24 Apr

Equillium Inc - Receives FDA Feedback on Itolizumab for Agvhd

THOMSON REUTERS
·
24 Apr

Equillium Inc - FDA Declines Breakthrough Therapy Designation for Itolizumab

THOMSON REUTERS
·
24 Apr

Equillium Announces Feedback from the U.S. Food and Drug Administration

Business Wire
·
24 Apr

EQ Resources Limited Appoints New Director

TIPRANKS
·
22 Apr

EQ Resources Strengthens Board with Industry Veteran Appointment

TIPRANKS
·
22 Apr

Equillium (EQ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks
·
01 Apr

EQ Resources Says Non-Executive Chairman to Become Executive Chairman on Interim Basis

MT Newswires Live
·
01 Apr

EQ Resources Strengthens Leadership Team with Key Appointments

TIPRANKS
·
01 Apr

Revenues Working Against Equillium, Inc.'s (NASDAQ:EQ) Share Price Following 47% Dive

Simply Wall St.
·
31 Mar

Equillium Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
28 Mar

Equillium Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
28 Mar

Leerink Partners Downgrades Equillium to Market Perform From Outperform, Adjusts Price Target to $1 From $3

MT Newswires Live
·
28 Mar

Equillium Inc : Leerink Partners Cuts to Market Perform From Outperform

THOMSON REUTERS
·
28 Mar

Equillium downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
28 Mar